U.S. Microarray Market Size, Share, Trends, Industry Analysis Report By Product and Services (Consumables, Software & Services, and Instruments), By Type, By Application, By End Use – Market Forecast, 2025–2034
Description
The U.S. microarray market size is expected to reach USD 4.45 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Microarray Market Size, Share, Trends, Industry Analysis Report By Product and Services (Consumables, Software & Services, Instruments), By Type, By Application, By End Use – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The U.S. microarray market focuses on the development, production, and application of sophisticated biochips that enable the high-throughput analysis of biological molecules. These microscopic arrays, typically made of glass, contain thousands of probes designed to detect specific DNA, RNA, or protein sequences. The technology enables the simultaneous measurement of gene expression levels, identification of genetic variations, and analysis of protein interactions, making it an essential tool in various scientific disciplines. Its primary function is to provide comprehensive molecular data efficiently, supporting advancements in both fundamental research and clinical applications.
The U.S. microarray market is experiencing significant growth and dynamic shifts. This growth is largely fueled by the increasing emphasis on personalized medicine, which relies heavily on detailed genetic and proteomic profiling achievable through microarrays. Investments from government bodies, such as the NIH, and private sector biotechnology companies into genomics and proteomics research are consistently driving innovation in the market. Furthermore, the rising prevalence of chronic diseases and cancer necessitates advanced diagnostic tools, for which microarrays offer critical capabilities in biomarker discovery and disease monitoring. These factors collectively contribute to a robust demand for microarray products and services across research institutions, pharmaceutical companies, and diagnostic laboratories.
U.S. Microarray Market Report Highlights
By product and services, the consumables segment held the largest share in 2024. This is attributed to the continuous and recurring demand for essential components such as slides, reagents, and kits needed for every experiment in research and diagnostic settings.
By type, the DNA microarrays segment held the largest share in 2024. Their widespread and established applications in gene expression profiling, SNP genotyping, and comparative genomic hybridization for research and clinical diagnostics significantly contribute to their leading position.
By application, the research applications segment held the largest share in 2024. This is driven by extensive use in academic institutions, biotechnology, and pharmaceutical companies for fundamental genomic and proteomic studies, biomarker discovery, and understanding disease mechanisms, supported by consistent funding.
By end use, the research & academic institutes segment held the largest share in 2024. Their pivotal role in basic and applied research, coupled with substantial funding for genomic and proteomic studies, drives their continuous and extensive adoption of microarray technologies.
Thermo Fisher Scientific Inc.; Agilent Technologies, Inc.; Illumina, Inc.; PerkinElmer Inc.; Merck KGaA; Bio-Rad Laboratories, Inc.; Arrayit Corporation; Microarrays Inc.; Molecular Devices, LLC (Danaher Corporation); and RayBiotech, Inc. are among the major key players in the U.S. microarray market.
Polaris Market Research has segmented the U.S. microarray market report on the basis of product and services, type, application, and end use:
By Product and Services Outlook (Revenue – USD Billion, 2020–2034)
Consumables
Software & Services
Instruments
By Type Outlook (Revenue – USD Billion, 2020–2034)
DNA Microarrays
Protein Microarrays
Others
By Application Outlook (Revenue – USD Billion, 2020–2034)
Research Applications
Drug Discovery
Disease Diagnostics
Others
By End Use Outlook (Revenue – USD Billion, 2020–2034)
Research & Academic Institutes
Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
Others
The U.S. microarray market focuses on the development, production, and application of sophisticated biochips that enable the high-throughput analysis of biological molecules. These microscopic arrays, typically made of glass, contain thousands of probes designed to detect specific DNA, RNA, or protein sequences. The technology enables the simultaneous measurement of gene expression levels, identification of genetic variations, and analysis of protein interactions, making it an essential tool in various scientific disciplines. Its primary function is to provide comprehensive molecular data efficiently, supporting advancements in both fundamental research and clinical applications.
The U.S. microarray market is experiencing significant growth and dynamic shifts. This growth is largely fueled by the increasing emphasis on personalized medicine, which relies heavily on detailed genetic and proteomic profiling achievable through microarrays. Investments from government bodies, such as the NIH, and private sector biotechnology companies into genomics and proteomics research are consistently driving innovation in the market. Furthermore, the rising prevalence of chronic diseases and cancer necessitates advanced diagnostic tools, for which microarrays offer critical capabilities in biomarker discovery and disease monitoring. These factors collectively contribute to a robust demand for microarray products and services across research institutions, pharmaceutical companies, and diagnostic laboratories.
U.S. Microarray Market Report Highlights
By product and services, the consumables segment held the largest share in 2024. This is attributed to the continuous and recurring demand for essential components such as slides, reagents, and kits needed for every experiment in research and diagnostic settings.
By type, the DNA microarrays segment held the largest share in 2024. Their widespread and established applications in gene expression profiling, SNP genotyping, and comparative genomic hybridization for research and clinical diagnostics significantly contribute to their leading position.
By application, the research applications segment held the largest share in 2024. This is driven by extensive use in academic institutions, biotechnology, and pharmaceutical companies for fundamental genomic and proteomic studies, biomarker discovery, and understanding disease mechanisms, supported by consistent funding.
By end use, the research & academic institutes segment held the largest share in 2024. Their pivotal role in basic and applied research, coupled with substantial funding for genomic and proteomic studies, drives their continuous and extensive adoption of microarray technologies.
Thermo Fisher Scientific Inc.; Agilent Technologies, Inc.; Illumina, Inc.; PerkinElmer Inc.; Merck KGaA; Bio-Rad Laboratories, Inc.; Arrayit Corporation; Microarrays Inc.; Molecular Devices, LLC (Danaher Corporation); and RayBiotech, Inc. are among the major key players in the U.S. microarray market.
Polaris Market Research has segmented the U.S. microarray market report on the basis of product and services, type, application, and end use:
By Product and Services Outlook (Revenue – USD Billion, 2020–2034)
Consumables
Software & Services
Instruments
By Type Outlook (Revenue – USD Billion, 2020–2034)
DNA Microarrays
Protein Microarrays
Others
By Application Outlook (Revenue – USD Billion, 2020–2034)
Research Applications
Drug Discovery
Disease Diagnostics
Others
By End Use Outlook (Revenue – USD Billion, 2020–2034)
Research & Academic Institutes
Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
Others
Table of Contents
128 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
